Cargando…
Choosing Appropriate Glucagon-like Peptide 1 Receptor Agonists: A Patient-Centered Approach
The individualized treatment of type 2 diabetes mellitus, using various glucagon-like peptide receptor agonists (GLP1RAs), has recently been described. As experience with existing GLP1RAs grows, and as newer molecules in the development pipeline continue to progress, interest related to these drugs...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer Healthcare
2014
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4065297/ https://www.ncbi.nlm.nih.gov/pubmed/24549850 http://dx.doi.org/10.1007/s13300-014-0058-y |